Dibb NJ - Search Results

1

Cell specific transformation by c-fms activating loop mutations is attributable to constitutive receptor degradation.

Morley GM, Uden M, Gullick WJ, Dibb NJ. Morley GM, et al. Among authors: dibb nj. Oncogene. 1999 May 20;18(20):3076-84. doi: 10.1038/sj.onc.1202646. Oncogene. 1999. PMID: 10340379

2

Evidence that downregulation of the M-CSF receptor is not dependent upon receptor kinase activity.

Uden M, Morley GM, Dibb NJ. Uden M, et al. Among authors: dibb nj. Oncogene. 1999 Jul 1;18(26):3846-51. doi: 10.1038/sj.onc.1202743. Oncogene. 1999. PMID: 10445847

3

Selection of activating mutations of c-fms in FDC-P1 cells.

Glover HR, Baker DA, Celetti A, Dibb NJ. Glover HR, et al. Among authors: dibb nj. Oncogene. 1995 Oct 5;11(7):1347-56. Oncogene. 1995. PMID: 7478556

4

Evidence for cell-specific differences in transformation by N-, H- and K-ras.

Maher J, Baker DA, Manning M, Dibb NJ, Roberts IA. Maher J, et al. Among authors: dibb nj. Oncogene. 1995 Oct 19;11(8):1639-47. Oncogene. 1995. PMID: 7478589

5

FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistance.

Taylor JR, Brownlow N, Domin J, Dibb NJ. Taylor JR, et al. Among authors: dibb nj. Oncogene. 2006 Jan 5;25(1):147-51. doi: 10.1038/sj.onc.1209007. Oncogene. 2006. PMID: 16170366

6

Synergy between SCF or M-CSF with IL-3 or GM-CSF in FDC-P1 cells: a sensitive assay of transforming mutations of c-fms.

Baker DA, Glover HR, Dibb NJ. Baker DA, et al. Among authors: dibb nj. Leukemia. 1994 Jan;8(1):141-50. Leukemia. 1994. PMID: 7507191

7

Biological activity of the receptor for macrophage colony-stimulating factor in the human endometrial cancer cell line, Ishikawa.

Takeda S, Soutter WP, Dibb NJ, White JO. Takeda S, et al. Among authors: dibb nj. Br J Cancer. 1996 Mar;73(5):615-9. doi: 10.1038/bjc.1996.106. Br J Cancer. 1996. PMID: 8605095 Free PMC article.

8

Evidence that ras and myc mediate the synergy between SCF or M-CSF and other haemopoietic growth factors.

Baker DA, Maher J, Roberts IA, Dibb NJ. Baker DA, et al. Among authors: dibb nj. Leukemia. 1994 Nov;8(11):1970-81. Leukemia. 1994. PMID: 7526094

9

Switching on kinases: oncogenic activation of BRAF and the PDGFR family.

Dibb NJ, Dilworth SM, Mol CD. Dibb NJ, et al. Nat Rev Cancer. 2004 Sep;4(9):718-27. doi: 10.1038/nrc1434. Nat Rev Cancer. 2004. PMID: 15343278 Review.

10

Mutant ras promotes haemopoietic cell proliferation or differentiation in a cell-specific manner.

Maher J, Baker D, Dibb N, Roberts I. Maher J, et al. Leukemia. 1996 Jan;10(1):83-90. Leukemia. 1996. PMID: 8558943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters